Hadassah

From Treating Symptoms to Restoring Health: Parkinson’s Progress at Hadassah

Monday, Feb 8 2016

With the long-term goal of replacing lost neurons and restoring function permanently to patients with Parkinson’s disease, Hadassah Medical Center physician/researchers in the Human Embryonic Stem Cell Center are uncovering crucial factors that affect the success of stem cell therapy.

In Parkinson's disease, progressive degeneration and loss of dopamine-producing neurons in the mid-brain cause motor and cognitive deficits, since dopamine is  essential to the normal functioning of the central nervous system. Whereas current treatment for Parkinson’s disease can only alleviate symptoms, regenerative therapy using stem cells targets the production of new dopamine. 

As Prof. Benjamin Reubinoff, head of the Stem Cell Center, explains: “To be able to produce a reasonable number of dopaminergic neurons from human embryonic stem cells, there is a need to refine some previously described protocols for directing the cells to differentiate.”

One of the factors Hadassah’s researchers are investigating is how the extracellular environment affects the process of differentiation. The culture plates, Prof. Reubinoff brings out, “provide an environment which is profoundly different from that of the intact soft tissue of the brain.” With this in mind, Dr. Sharona Even Ram from the Stem Cell Center developed a method to grow cells in modified 3D soft culture conditions and compared the results to those achieved using the hard plastic plates. Subsequently, they followed changes on the cellular and molecular level along the differentiation process. “Indeed we found that soft and hard substrates have different capacity of supporting neuronal maturation,” reports Prof. Reubinoff.

Another challenge that scientists face in the stem cell differentiation process in culture (in vitro) is that some of the cells retain what is called their “stemness.”  In other words, they fail to mature, but at the same time they show high proliferation rates. These cells bear the risk of forming tumors after transplantation, which has been seen worldwide in animal models. Therefore, Prof. Reubinoff and Dr. Even Ram are investigating techniques to “clean the culture,” eliminating these cells before transplantation takes place.

Having characterized the changes in cell components that normally occur as stem cells differentiate, the researchers are able to identify specific elements that mature cells carry which endow them with increased resistance to toxic agents. They found that immature proliferating cells do not contain these elements, and therefore can be eliminated by specific toxic agents. One of the methods they are using, Prof. Reubinoff reports, has been recently patented in the United States.

A third issue that Hadassah researchers have tackled is the enhancement of the neuron’s survival once it has been transplanted to the host tissue.

A challenge in this step is that the compromised brain of the Parkinson’s patient may not provide a hospitable environment for the newly transplanted cells. To deal with this issue, they are working toward supplying extracellular materials that will enable the cells to attach to the host and survive, long-term. Prof. Reubinoff reports that Hadassah’s team is collaborating with a group from Tokyo, Japan to test materials for their ability to support neuronal growth and maturation, such as laminin peptides. They are also involved in a joint exploration with a group from Nottingham, United Kingdom to test biodegradable micro-particles as a cell delivery method, which would facilitate a slow release of growth factors--here again enhancing the cell’s survival potential. This is being tested in culture and in an animal model.

While there are clearly hurdles to overcome in ensuring the success of regenerative therapy for Parkinson’s disease, stem cells hold great promise for a transformation from treating symptoms to restoring health.

Comments

From: juliet on June 29, 2016
hello viewer's Am Juliet i live in USA ...i don't have much to say there are so may scam going on online so we cant detect the real herbal medicine doctors .thank GOD for leading me,please don't ignore this post is real DR MAPIPA, is a real herbal Doctor ,he cured me and my husband from Parkinson's and COPD ,we are living so happy and free ,we were full recovered within 4 weeks of usage of dr mapipa herbal medicine ,please viewers out there that have any deadly disease dont fail contact him via his email;drmapipaherbalmedicinehome(at)gmail(dot)com,and website www(dot)drmapipaherbal(dot)weebly(dot)com..thanks once again to dr mapipa GOD bless you abundantly....
From: Judith on February 16, 2016
I have become a Hadassah Research junkie. Am taking my Israeli family From Tel Aviv area to see the Tower when I return to Israel In May. Avis
From: Stacey Dorenfeld on February 13, 2016
This is why I have become an advocate for Hadassah. I can't wait to visit the hospital when I am in Israel on March 3.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Dec 7 2016

Saturday Night Lively: Hadassah Israel Fundraiser Wows Largely Orthodox Audience of 1200

Hadassah International Israel (HII) drew over 1200 men and women to a concert at Tel Aviv University, targeting the funds raised for renovation of the rehabilitation facilities at Hadassah Hospital Mount Scopus.

READ MORE ›
alt_text

Monday, Dec 5 2016

Celebrated Israeli Psychiatrist/Neurobiologist To Join Hadassah Medical Staff

Prof. Yoram Yovell, renowned Israeli psychiatrist and neurobiologist, will soon be joining the Hadassah Medical Organization’s “brain medicine branch,” which includes the departments of psychiatry, neurology, and neurosurgery and is under the direction of Prof. Tamir Ben-Hur.

READ MORE ›
alt_text

Wednesday, Nov 30 2016

Hadassah Teams Up with Spinal Cord Institute to Study Outcomes of Traumatic Injuries

The medical interventions and outcomes for Israelis with a spinal cord injury (SCI) will now be captured in the Rick Hansen SCI Registry (RHSCIR), thanks to the November 16th launch of a partnership between the Hadassah Medical Organization and the Rick Hansen Institute (RHI), a Canadian-based not-for-profit organization named after the paralympic athlete who suffered a severe spinal cord injury following a car accident.

READ MORE ›
alt_text

Thursday, Nov 17 2016

Ethiopian Pre-Nursing Students: On the Way to Fulfilling a Dream

“I know that some people are fine with looking at a screen all day, but I know I need the human touch--to work with people. I want to be a nurse, " relates Sarah Talala, one of the 18 students of Ethiopian background who were given the opportunity to take a course which enabled them to advance to pre-academic studies at the Hebrew University and then on to nursing school at the Hadassah-Hebrew University Henrietta Szold School of Nursing.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More